A-TANGO strives to increase the survival rate with G-TAK – a novel combinatorial therapy, and to decrease the burden on the national healthcare systems, which is caused by a large percentage of patients who never recover fully and require long-term care.
Read more about the projectWednesday 7 May
| When | Where | What |
| 14:00-15:00 | D202 (Level 2 of the Elicium Building) | A-TANGO Patient & Layman Event
Speakers: Marko Korenjak (ELPA), Rajiv Jalan (UCL), and Cornelius Engelmann (Charité) Organiser: European Liver Patients‘ Association (ELPA) |
| 17:45-17:50 | Arnold Room | Opening remarks - addressing disparities in healthcare in the Netherlands
|
| 08:30-17:00 | Poster Area (also available as ePoster) | POSTER ID WED-437: suPAR levels independently discriminate patients with at-risk MASLD
Presenter: Julian Pohl (Charité) |
Thursday 8 May
| When | Where | What |
| 15:35-15:45 | Erlinger Room | Managing financial conflicts of interest
|
| 17:00-19:00 | D202 (Level 2 of the Elicium Building) | A-TANGO Investigator & Industry Meeting
|
| 08:30-17:00 | Poster Area (also available as ePoster) | POSTER ID TOP-203 Recombinant insulin-like growth factor-1: a novel therapy for patients with cirrhosis and ACLF
|
Friday 9 May
| When | Where | What |
| 08:30-17:00 | Poster Area (also available as ePoster) | POSTER ID TOP-217-YI Pathophysiological basis of acute on chronic liver failure (ACLF) triggered by alcohol-related hepatitis or infection using circulating biomarkers of inflammation, circulatory dysfunction and albumin modifications
Presenter: Julian Pohl (Charité) |
| 08:30-17:00 | Poster Area (also available as ePoster) | POSTER ID FRI-192 Loss of paraspinal skeletal muscle tissue is independently associated with increased 90-, but not 28-day mortality in patients with acute-on-chronic liver failure
Presenter: Julian Pohl (Charité) |
| 08:30-17:00 | Poster Area (also available as ePoster) | POSTER ID FRI-156 Coordinated liver tissue regeneration becomes ineffective with increasing injury in patients with acute indeterminate liver failure
Presenter: Richard Sittner (Charité) |
Saturday 10 May
| When | Where | What |
| 08:30-16:00 | Poster Area (also available as ePoster) | POSTER ID SAT-210 Development and validation of the modified hepatic encephalopathy staging tool (mHEST) for grading of hepatic encephalopathy for accurate assessment and regulated clinical trials
Presenter: Rajiv Jalan (UCL) |
| 08:30-16:00 | Poster Area (also available as ePoster) | POSTER ID SAT-209 Randomized, open-label, phase 2a comparator study to assess the pharmacodynamics, safety and pharmacokinetics of oral administration of mnk6106 (l-ornithine phenylacetate) vs. rifaximin in subjects with hepatic cirrhosis and a previous history of hepatic encephalopathy
Presenter: Rajiv Jalan (UCL) |
| 09:45-10:15 | Cirrhosis & Complications Track Hub | A-TANGO Networking Session
Speakers: Rajiv Jalan (UCL) and Young Investigators (YI) of A-TANGO |
| 10:35-10:50 | Eddleston Room | Table 2: Delphi Method
|
| 14:45-14:55 | Benhamou Room | Viral hepatitis
|